# ğŸ¯ Complete Backtesting Analysis: 2018 vs 2010 Start Dates

**Generated**: November 8, 2025  
**Purpose**: Compare short-term (2018-2025) vs extended (2010-2025) backtesting results

---

## Overview

We've now completed **two comprehensive backtests** of the enhanced 27-feature ML model:

1. **Original Validation** (2018-2025): 7.9 years total, 1.3 years test
2. **Extended Validation** (2010-2025): 15.8 years total, 4.9 years test

This document compares the results to understand the **true predictive edge** of the strategy.

---

## Test Period Comparison

### Original Test (2024-2025): 482 days

| Pair | Return | Sharpe | Status |
|------|--------|--------|--------|
| **AUD/USD** | +34.50% | **3.765** | ğŸ‰ Exceptional |
| **USD/JPY** | +27.00% | **1.589** | âœ… Good |
| **EUR/USD** | +1.59% | 0.297 | âš ï¸ Weak |
| **Average** | **+21.03%** | **1.88** | ğŸ‰ Excellent |

### Extended Test (2021-2025): 1,242 days

| Pair | Return | Sharpe | Status |
|------|--------|--------|--------|
| **USD/JPY** | +169.14% | **0.450** | âœ… Good |
| **USD/CAD** | +61.43% | **0.477** | âœ… Good |
| **EUR/USD** | +21.91% | 0.094 | âš ï¸ Weak |
| **AUD/USD** | +6.24% | **0.016** | âŒ Very Weak |
| **GBP/USD** | +4.42% | 0.019 | âš ï¸ Weak |
| **USD/CHF** | -3.43% | -0.011 | âŒ Negative |
| **NZD/USD** | -87.82% | -0.323 | âŒ Very Negative |
| **Average** | **+24.56%** | **0.103** | âš ï¸ Marginal |

---

## Critical Finding: AUD/USD Reality Check âš ï¸

### The Illusion

**Short-term (2024-2025)**:
- Return: +34.50%
- Sharpe: **3.765** â† Top performer!
- Status: "Excellent! Ready for trading!"

**Long-term (2021-2025)**:
- Return: +6.24% 
- Sharpe: **0.016** â† Essentially random!
- Status: "No edge - do not trade"

### What Happened?

The **2024-2025 period was exceptionally favorable** for AUD/USD momentum strategies:
- Strong trending behavior in AUD
- Favorable commodity price movements
- Interest rate differential dynamics

But this was **NOT representative** of the pair's behavior over longer periods.

### Lesson Learned

> **Never trust results from just 1-2 years of data!**  
> Always validate on at least 5+ years to capture different market regimes.

---

## USD/JPY: The Consistent Winner âœ…

### Performance Across Both Tests

**Short-term (2024-2025)**:
- Return: +27.00%
- Sharpe: 1.589
- Max DD: -27.76%

**Long-term (2021-2025)**:
- Return: +169.14% (over 5 years)
- Sharpe: 0.450
- Strong trending in 2021-2023 yen weakness

### Analysis

USD/JPY shows **consistent positive edge** across both test periods:
- **Substantial total returns** (+169% over 5 years)
- **Reasonable Sharpe** (0.45 is good for FX)
- **Captures major trends** (BOJ policy, rate differentials)

âœ… **Verdict**: USD/JPY is the most **reliable** pair for this strategy

---

## EUR/USD: Consistently Difficult ğŸ˜

### Performance Across Both Tests

**Short-term (2024-2025)**:
- Return: +1.59%
- Sharpe: 0.297

**Long-term (2021-2025)**:
- Return: +21.91%
- Sharpe: 0.094

### Analysis

EUR/USD shows **low but positive edge** across all periods:
- Most liquid FX pair = **hardest to predict**
- Consistently low Sharpe ratios
- Small but positive returns

âš ï¸ **Verdict**: EUR/USD has weak edge but might contribute to portfolio diversification

---

## USD/CAD: Hidden Gem ğŸ’

### Why We Missed It Initially

USD/CAD wasn't in the original 2024-2025 validation but shows **strong performance** in the extended test:

**Long-term (2021-2025)**:
- Return: +61.43%
- Sharpe: **0.477** â† Second best!
- Status: Reliable performer

### Analysis

- Benefits from **oil price dynamics** (Canada is oil exporter)
- Clear **momentum patterns** in CAD
- **Lower correlation** with other pairs

âœ… **Verdict**: USD/CAD is a strong candidate for the portfolio

---

## Statistical Significance Analysis

### Sample Size Comparison

| Test | Days | Years | Trades/Pair | Statistical Power |
|------|------|-------|-------------|------------------|
| **Short-term** | 482 | 1.3 | 19-46 | âš ï¸ Limited |
| **Extended** | 1,242 | 4.9 | 31-93 | âœ… Good |

### Market Regime Coverage

**Short-term (2024-2025)**:
- Captured: Post-COVID normalization, rate hiking cycle
- Missed: COVID crash (2020), Euro crisis (2011-2012), taper tantrum (2013)

**Extended (2021-2025)**:
- Captured: COVID recovery, rate hiking, policy divergence
- Still missed: COVID crash, Euro crisis, taper tantrum

**Full Training (2010-2020)**:
- Includes: Euro crisis, taper tantrum, 2015 China crash, 2018 vol spike
- Missing: COVID crash (happened after training cutoff)

---

## Sharpe Ratio Reality Check

### Distribution of Sharpe Ratios

**Short-term test (2024-2025)**:
- Range: 0.297 to 3.765
- Average: 1.88
- Median: 1.589
- 67% above 1.0 (excellent)

**Extended test (2021-2025)**:
- Range: -0.323 to 0.477
- Average: 0.103
- Median: 0.094
- 0% above 1.0 (none excellent)

### What's Realistic for FX?

| Sharpe | Rating | Typical Strategy |
|--------|--------|------------------|
| **> 2.0** | ğŸ‰ Exceptional | Top quant funds, very rare |
| **1.0-2.0** | âœ… Excellent | Good systematic strategies |
| **0.5-1.0** | âœ… Good | Profitable but volatile |
| **0.2-0.5** | âš ï¸ Marginal | Barely profitable |
| **< 0.2** | âŒ Weak | Not worth trading |

### Our Results

- **Short-term**: 1.88 Sharpe â†’ **Too good to be true** (and it was!)
- **Extended**: 0.10 Sharpe â†’ **Realistic but marginal**

---

## Updated Portfolio Recommendation

### Original Recommendation (Based on 2024-2025)

**Portfolio**: AUD/USD + USD/JPY + EUR/USD  
**Expected Sharpe**: 1.5-2.0  
**Confidence**: High âœ…

### Revised Recommendation (Based on 2021-2025)

**Portfolio**: USD/JPY + USD/CAD (+ EUR/USD optional)  
**Expected Sharpe**: 0.25-0.35  
**Confidence**: Medium âš ï¸

### Detailed Allocation

| Pair | Allocation | Rationale |
|------|-----------|-----------|
| **USD/JPY** | 40-50% | Most consistent, highest returns |
| **USD/CAD** | 40-50% | Strong Sharpe, uncorrelated to JPY |
| **EUR/USD** | 0-20% | Optional diversifier, weak edge |
| **Others** | 0% | Insufficient edge over long term |

---

## Risk-Adjusted Expectations

### Optimistic Scenario (2024-2025 repeats)
- Annual Return: 15-25%
- Sharpe Ratio: 1.0-1.5
- Max Drawdown: -20% to -30%

### Realistic Scenario (2021-2025 typical)
- Annual Return: 10-15%
- Sharpe Ratio: 0.25-0.35
- Max Drawdown: -30% to -40%

### Conservative Scenario (challenging markets)
- Annual Return: 0-5%
- Sharpe Ratio: 0.0-0.15
- Max Drawdown: -40% to -50%

### With 1bp Transaction Costs

Subtract ~1-2% annually from all returns above.

---

## Lessons Learned

### 1. Short-term results can be misleading âš ï¸

The spectacular **AUD/USD performance (+34.5% / 3.765 Sharpe)** in 2024-2025 was **not representative** of long-term edge.

**Lesson**: Always validate on 5+ years of data

### 2. Different pairs perform differently over time ğŸ“Š

- **USD/JPY**: Consistently good across all periods
- **AUD/USD**: Amazing short-term, weak long-term
- **USD/CAD**: Not tested short-term, strong long-term

**Lesson**: Test multiple currency pairs and time periods

### 3. Extended testing reduces overconfidence âœ…

- **Short-term**: "Excellent strategy! Sharpe 1.88!"
- **Long-term**: "Marginal strategy. Sharpe 0.10."

**Lesson**: Longer tests give more realistic expectations

### 4. Market regimes matter ğŸŒ

The 2024-2025 period had unique characteristics:
- Post-COVID normalization
- Aggressive rate hiking
- Strong trends in JPY and AUD

These conditions won't persist forever.

**Lesson**: Strategy performance varies significantly by regime

---

## Next Steps & Action Items

### Immediate (Week 1)

1. âœ… **Set up paper trading** for USD/JPY and USD/CAD
2. âœ… **Use 25% position sizing** (conservative)
3. âœ… **Monitor for 1 month** before adding capital

### Short-term (Month 1-3)

4. âœ… **Track live vs backtest performance**
5. âœ… **Add transaction cost modeling** (1bp per trade)
6. âš ï¸ **Fix drawdown calculation bug** in backtest code
7. âœ… **Test on 10+ additional currency pairs**

### Medium-term (Month 3-6)

8. âœ… **Implement walk-forward validation** (retrain quarterly)
9. âœ… **Build portfolio optimization** (mean-variance, risk parity)
10. âœ… **Add risk management** (volatility targeting, max DD limits)

### Long-term (Month 6-12)

11. âœ… **Consider going live** if paper trading successful
12. âœ… **Start with $10k-25k** (small capital)
13. âœ… **Scale up gradually** based on live track record

---

## Final Verdict

### Previous Assessment (After 2024-2025 Test)

> ğŸ‰ **"EXCELLENT! Strategy shows strong performance over 1.3 years"**  
> âœ… **"Ready for paper trading"**  
> ğŸ“ˆ **Average Sharpe: 1.88**  
> Confidence: High

### Updated Assessment (After 2021-2025 Extended Test)

> âš ï¸ **"MARGINAL. Strategy shows weak positive edge over 5 years"**  
> ğŸ’¡ **"May need further optimization or selective pair trading"**  
> ğŸ“ˆ **Average Sharpe: 0.10**  
> Confidence: Medium

### What Changed?

The extended test revealed that:

1. **2024-2025 was exceptionally favorable** (not representative)
2. **True long-term edge is much weaker** (Sharpe 0.10 vs 1.88)
3. **Only 2 pairs consistently profitable** (USD/JPY, USD/CAD)
4. **AUD/USD was period-specific** (not a reliable strategy)

### Should We Still Trade It?

**YES, but with:**
- âœ… Focus on USD/JPY + USD/CAD only
- âœ… Conservative position sizing (25% of backtest)
- âœ… Realistic expectations (Sharpe 0.25-0.35, not 1.88)
- âœ… 6-month paper trading validation
- âœ… Stop trading if live Sharpe < 0 after 6 months

**NO, if:**
- âŒ You expected the 1.88 Sharpe to persist
- âŒ You can't tolerate 12-18 month drawdown periods
- âŒ You need consistent month-to-month profits
- âŒ You can't accept 0.10 average Sharpe as acceptable

---

## Conclusion

The extended backtesting from 2010 provides **critical perspective**:

- Short-term (2024-2025): **Misleadingly optimistic**
- Extended (2021-2025): **More realistic**
- True edge: **Weak but positive** (Sharpe 0.10-0.45 depending on pair)

**Recommendation**: Proceed to **conservative paper trading** with **USD/JPY and USD/CAD** only. Expect **modest returns** (10-15% annually) with **moderate risk** (30-40% drawdowns).

This is **not a get-rich-quick strategy**, but it may have a **small tradeable edge** worth exploiting with proper risk management.

---

**Files Referenced**:
- `BACKTEST_VALIDATION_REPORT.md` (2024-2025 validation)
- `EXTENDED_BACKTEST_2010_SUMMARY.md` (2021-2025 validation)
- `backtest_extended_2010_results.csv` (full results)
- `extended_backtest_2010_summary.png` (visual summary)

**Generated**: November 8, 2025  
**Status**: âœ… Extended validation complete, ready for conservative paper trading
